Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global IVD Antibody Market Research Report 2026

Global IVD Antibody Market Research Report 2026

Industry: Medical Devices & Consumables

Published Date: 2026-04-17

Pages: 110 Pages

Report ld: 6468397

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

IVD Antibody Market Size(US$)

CAGR 2026-2032

8.0%

Market Size,2032

USD 1,699

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,071 million

Market Forecast in 2032(Value)

US$ 1,699 million

CAGR

8.0%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global IVD Antibody market was valued at US$ 999 million in 2025 and is anticipated to reach US$ 1699 million by 2032, at a CAGR of 8.0% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on IVD Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

IVD Antibody

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global IVD Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding IVD Antibody. The IVD Antibody market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global IVD Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist IVD Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

BD PharMingen
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Santa Cruz Biotechnologies
Beckman Coulter
Roche/Ventana

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

mAb
pAb
rAbs

Segment by Application

RIA
ELISA
CLIA
LFIA
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for IVD Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.

Chapter 3: Examines IVD Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.

Chapter 7: Reviews the industry value chain, including upstream and downstream segments.

Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 9: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 IVD Antibody Market Overview

1.1 Product Definition

1.2 IVD Antibody by Type

1.2.1 Global IVD Antibody Market Value by Type: 2025 vs 2032

1.2.2 mAb

1.2.3 pAb

1.2.4 rAbs

1.3 IVD Antibody by Application

1.3.1 Global IVD Antibody Market Value by Application: 2025 vs 2032

1.3.2 RIA

1.3.3 ELISA

1.3.4 CLIA

1.3.5 LFIA

1.3.6 Other

1.4 Global IVD Antibody Market Size Estimates and Forecasts

1.4.1 Global IVD Antibody Revenue 2021–2032

1.4.2 Global IVD Antibody Sales 2021–2032

1.4.3 Global IVD Antibody Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 IVD Antibody Market Competition by Manufacturers

2.1 Global IVD Antibody Sales Market Share by Manufacturers (2021–2026)

2.2 Global IVD Antibody Revenue Market Share by Manufacturers (2021–2026)

2.3 Global IVD Antibody Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of IVD Antibody, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of IVD Antibody, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of IVD Antibody, Product Types and Applications

2.7 Global Key Manufacturers of IVD Antibody, Date of Entry into the Industry

2.8 Global IVD Antibody Market Competitive Situation and Trends

2.8.1 Global IVD Antibody Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global IVD Antibody Players Market Share by Revenue

2.8.3 Global IVD Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global IVD Antibody Market Scenario by Region

3.1 Global IVD Antibody Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global IVD Antibody Sales by Region: 2021–2032

3.2.1 Global IVD Antibody Sales by Region: 2021–2026

3.2.2 Global IVD Antibody Sales by Region: 2027–2032

3.3 Global IVD Antibody Revenue by Region: 2021–2032

3.3.1 Global IVD Antibody Revenue by Region: 2021–2026

3.3.2 Global IVD Antibody Revenue by Region: 2027–2032

3.4 North America IVD Antibody Market Facts & Figures by Country

3.4.1 North America IVD Antibody Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America IVD Antibody Sales by Country (2021–2032)

3.4.3 North America IVD Antibody Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe IVD Antibody Market Facts & Figures by Country

3.5.1 Europe IVD Antibody Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe IVD Antibody Sales by Country (2021–2032)

3.5.3 Europe IVD Antibody Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific IVD Antibody Market Facts & Figures by Region

3.6.1 Asia Pacific IVD Antibody Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific IVD Antibody Sales by Region (2021–2032)

3.6.3 Asia Pacific IVD Antibody Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America IVD Antibody Market Facts & Figures by Country

3.7.1 Latin America IVD Antibody Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America IVD Antibody Sales by Country (2021–2032)

3.7.3 Latin America IVD Antibody Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa IVD Antibody Market Facts & Figures by Country

3.8.1 Middle East and Africa IVD Antibody Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa IVD Antibody Sales by Country (2021–2032)

3.8.3 Middle East and Africa IVD Antibody Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global IVD Antibody Sales by Type (2021–2032)

4.1.1 Global IVD Antibody Sales by Type (2021–2026)

4.1.2 Global IVD Antibody Sales by Type (2027–2032)

4.1.3 Global IVD Antibody Sales Market Share by Type (2021–2032)

4.2 Global IVD Antibody Revenue by Type (2021–2032)

4.2.1 Global IVD Antibody Revenue by Type (2021–2026)

4.2.2 Global IVD Antibody Revenue by Type (2027–2032)

4.2.3 Global IVD Antibody Revenue Market Share by Type (2021–2032)

4.3 Global IVD Antibody Price by Type (2021–2032)

5 Segment by Application

5.1 Global IVD Antibody Sales by Application (2021–2032)

5.1.1 Global IVD Antibody Sales by Application (2021–2026)

5.1.2 Global IVD Antibody Sales by Application (2027–2032)

5.1.3 Global IVD Antibody Sales Market Share by Application (2021–2032)

5.2 Global IVD Antibody Revenue by Application (2021–2032)

5.2.1 Global IVD Antibody Revenue by Application (2021–2026)

5.2.2 Global IVD Antibody Revenue by Application (2027–2032)

5.2.3 Global IVD Antibody Revenue Market Share by Application (2021–2032)

5.3 Global IVD Antibody Price by Application (2021–2032)

6 Key Companies Profiled

6.1 BD PharMingen

6.1.1 BD PharMingen Company Information

6.1.2 BD PharMingen Description and Business Overview

6.1.3 BD PharMingen IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 BD PharMingen IVD Antibody Product Portfolio

6.1.5 BD PharMingen Recent Developments/Updates

6.2 Abcam

6.2.1 Abcam Company Information

6.2.2 Abcam Description and Business Overview

6.2.3 Abcam IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Abcam IVD Antibody Product Portfolio

6.2.5 Abcam Recent Developments/Updates

6.3 R&D Systems

6.3.1 R&D Systems Company Information

6.3.2 R&D Systems Description and Business Overview

6.3.3 R&D Systems IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 R&D Systems IVD Antibody Product Portfolio

6.3.5 R&D Systems Recent Developments/Updates

6.4 Cell Signaling Technology

6.4.1 Cell Signaling Technology Company Information

6.4.2 Cell Signaling Technology Description and Business Overview

6.4.3 Cell Signaling Technology IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Cell Signaling Technology IVD Antibody Product Portfolio

6.4.5 Cell Signaling Technology Recent Developments/Updates

6.5 Affymatrix

6.5.1 Affymatrix Company Information

6.5.2 Affymatrix Description and Business Overview

6.5.3 Affymatrix IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Affymatrix IVD Antibody Product Portfolio

6.5.5 Affymatrix Recent Developments/Updates

6.6 BioLegend

6.6.1 BioLegend Company Information

6.6.2 BioLegend Description and Business Overview

6.6.3 BioLegend IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 BioLegend IVD Antibody Product Portfolio

6.6.5 BioLegend Recent Developments/Updates

6.7 Santa Cruz Biotechnologies

6.7.1 Santa Cruz Biotechnologies Company Information

6.7.2 Santa Cruz Biotechnologies Description and Business Overview

6.7.3 Santa Cruz Biotechnologies IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Santa Cruz Biotechnologies IVD Antibody Product Portfolio

6.7.5 Santa Cruz Biotechnologies Recent Developments/Updates

6.8 Beckman Coulter

6.8.1 Beckman Coulter Company Information

6.8.2 Beckman Coulter Description and Business Overview

6.8.3 Beckman Coulter IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Beckman Coulter IVD Antibody Product Portfolio

6.8.5 Beckman Coulter Recent Developments/Updates

6.9 Roche/Ventana

6.9.1 Roche/Ventana Company Information

6.9.2 Roche/Ventana Description and Business Overview

6.9.3 Roche/Ventana IVD Antibody Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Roche/Ventana IVD Antibody Product Portfolio

6.9.5 Roche/Ventana Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 IVD Antibody Industry Chain Analysis

7.2 IVD Antibody Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 IVD Antibody Production Mode & Process Analysis

7.4 IVD Antibody Sales and Marketing

7.4.1 IVD Antibody Sales Channels

7.4.2 IVD Antibody Distributors

7.5 IVD Antibody Customer Analysis

8 IVD Antibody Market Dynamics

8.1 IVD Antibody Industry Trends

8.2 IVD Antibody Market Drivers

8.3 IVD Antibody Market Challenges

8.4 IVD Antibody Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global IVD Antibody Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global IVD Antibody Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global IVD Antibody Market Competitive Situation by Manufacturers in 2025

Table 4. Global IVD Antibody Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global IVD Antibody Sales Market Share by Manufacturers (2021–2026)

Table 6. Global IVD Antibody Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global IVD Antibody Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market IVD Antibody Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of IVD Antibody, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of IVD Antibody, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of IVD Antibody, Product Types and Applications

Table 12. Global Key Manufacturers of IVD Antibody, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global IVD Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on IVD Antibody Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global IVD Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global IVD Antibody Sales by Region (K Units), 2021–2026

Table 18. Global IVD Antibody Sales Market Share by Region (2021–2026)

Table 19. Global IVD Antibody Sales by Region (K Units), 2027–2032

Table 20. Global IVD Antibody Sales Market Share by Region (2027–2032)

Table 21. Global IVD Antibody Revenue by Region (US$ Million), 2021–2026

Table 22. Global IVD Antibody Revenue Market Share by Region (2021–2026)

Table 23. Global IVD Antibody Revenue by Region (US$ Million), 2027–2032

Table 24. Global IVD Antibody Revenue Market Share by Region (2027–2032)

Table 25. North America IVD Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America IVD Antibody Sales by Country (K Units), 2021–2026

Table 27. North America IVD Antibody Sales by Country (K Units), 2027–2032

Table 28. North America IVD Antibody Revenue by Country (US$ Million), 2021–2026

Table 29. North America IVD Antibody Revenue by Country (US$ Million), 2027–2032

Table 30. Europe IVD Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe IVD Antibody Sales by Country (K Units), 2021–2026

Table 32. Europe IVD Antibody Sales by Country (K Units), 2027–2032

Table 33. Europe IVD Antibody Revenue by Country (US$ Million), 2021–2026

Table 34. Europe IVD Antibody Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific IVD Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific IVD Antibody Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific IVD Antibody Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific IVD Antibody Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific IVD Antibody Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America IVD Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America IVD Antibody Sales by Country (K Units), 2021–2026

Table 42. Latin America IVD Antibody Sales by Country (K Units), 2027–2032

Table 43. Latin America IVD Antibody Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America IVD Antibody Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa IVD Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa IVD Antibody Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa IVD Antibody Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa IVD Antibody Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa IVD Antibody Revenue by Country (US$ Million), 2027–2032

Table 50. Global IVD Antibody Sales (K Units) by Type (2021–2026)

Table 51. Global IVD Antibody Sales (K Units) by Type (2027–2032)

Table 52. Global IVD Antibody Sales Market Share by Type (2021–2026)

Table 53. Global IVD Antibody Sales Market Share by Type (2027–2032)

Table 54. Global IVD Antibody Revenue (US$ Million) by Type (2021–2026)

Table 55. Global IVD Antibody Revenue (US$ Million) by Type (2027–2032)

Table 56. Global IVD Antibody Revenue Market Share by Type (2021–2026)

Table 57. Global IVD Antibody Revenue Market Share by Type (2027–2032)

Table 58. Global IVD Antibody Price (US$/Unit) by Type (2021–2026)

Table 59. Global IVD Antibody Price (US$/Unit) by Type (2027–2032)

Table 60. Global IVD Antibody Sales (K Units) by Application (2021–2026)

Table 61. Global IVD Antibody Sales (K Units) by Application (2027–2032)

Table 62. Global IVD Antibody Sales Market Share by Application (2021–2026)

Table 63. Global IVD Antibody Sales Market Share by Application (2027–2032)

Table 64. Global IVD Antibody Revenue (US$ Million) by Application (2021–2026)

Table 65. Global IVD Antibody Revenue (US$ Million) by Application (2027–2032)

Table 66. Global IVD Antibody Revenue Market Share by Application (2021–2026)

Table 67. Global IVD Antibody Revenue Market Share by Application (2027–2032)

Table 68. Global IVD Antibody Price (US$/Unit) by Application (2021–2026)

Table 69. Global IVD Antibody Price (US$/Unit) by Application (2027–2032)

Table 70. BD PharMingen Company Information

Table 71. BD PharMingen Description and Business Overview

Table 72. BD PharMingen IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. BD PharMingen IVD Antibody Product

Table 74. BD PharMingen Recent Developments/Updates

Table 75. Abcam Company Information

Table 76. Abcam Description and Business Overview

Table 77. Abcam IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Abcam IVD Antibody Product

Table 79. Abcam Recent Developments/Updates

Table 80. R&D Systems Company Information

Table 81. R&D Systems Description and Business Overview

Table 82. R&D Systems IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. R&D Systems IVD Antibody Product

Table 84. R&D Systems Recent Developments/Updates

Table 85. Cell Signaling Technology Company Information

Table 86. Cell Signaling Technology Description and Business Overview

Table 87. Cell Signaling Technology IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Cell Signaling Technology IVD Antibody Product

Table 89. Cell Signaling Technology Recent Developments/Updates

Table 90. Affymatrix Company Information

Table 91. Affymatrix Description and Business Overview

Table 92. Affymatrix IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Affymatrix IVD Antibody Product

Table 94. Affymatrix Recent Developments/Updates

Table 95. BioLegend Company Information

Table 96. BioLegend Description and Business Overview

Table 97. BioLegend IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. BioLegend IVD Antibody Product

Table 99. BioLegend Recent Developments/Updates

Table 100. Santa Cruz Biotechnologies Company Information

Table 101. Santa Cruz Biotechnologies Description and Business Overview

Table 102. Santa Cruz Biotechnologies IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. Santa Cruz Biotechnologies IVD Antibody Product

Table 104. Santa Cruz Biotechnologies Recent Developments/Updates

Table 105. Beckman Coulter Company Information

Table 106. Beckman Coulter Description and Business Overview

Table 107. Beckman Coulter IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Beckman Coulter IVD Antibody Product

Table 109. Beckman Coulter Recent Developments/Updates

Table 110. Roche/Ventana Company Information

Table 111. Roche/Ventana Description and Business Overview

Table 112. Roche/Ventana IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Roche/Ventana IVD Antibody Product

Table 114. Roche/Ventana Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. IVD Antibody Distributors List

Table 118. IVD Antibody Customers List

Table 119. IVD Antibody Market Trends

Table 120. IVD Antibody Market Drivers

Table 121. IVD Antibody Market Challenges

Table 122. IVD Antibody Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of IVD Antibody

Figure 2. Global IVD Antibody Market Value by Type (US$ Million), 2021–2032

Figure 3. Global IVD Antibody Market Share by Type: 2025 & 2032

Figure 4. mAb Product Picture

Figure 5. pAb Product Picture

Figure 6. rAbs Product Picture

Figure 7. Global IVD Antibody Market Value by Application (US$ Million), 2021–2032

Figure 8. Global IVD Antibody Market Share by Application: 2025 & 2032

Figure 9. RIA

Figure 10. ELISA

Figure 11. CLIA

Figure 12. LFIA

Figure 13. Other

Figure 14. Global IVD Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global IVD Antibody Market Size (US$ Million), 2021–2032

Figure 16. Global IVD Antibody Sales (K Units), 2021–2032

Figure 17. Global IVD Antibody Average Price (US$/Unit), 2021–2032

Figure 18. IVD Antibody Report Years Considered

Figure 19. IVD Antibody Sales Share by Manufacturers in 2025

Figure 20. Global IVD Antibody Revenue Share by Manufacturers in 2025

Figure 21. Top 5 and Top 10 Global IVD Antibody Players: Market Share by Revenue in IVD Antibody in 2025

Figure 22. IVD Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 23. Global IVD Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 24. North America IVD Antibody Sales Market Share by Country (2021–2032)

Figure 25. North America IVD Antibody Revenue Market Share by Country (2021–2032)

Figure 26. United States IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. Canada IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. Europe IVD Antibody Sales Market Share by Country (2021–2032)

Figure 29. Europe IVD Antibody Revenue Market Share by Country (2021–2032)

Figure 30. Germany IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. France IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. U.K. IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Italy IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Russia IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Asia Pacific IVD Antibody Sales Market Share by Region (2021–2032)

Figure 36. Asia Pacific IVD Antibody Revenue Market Share by Region (2021–2032)

Figure 37. China IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Japan IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. South Korea IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. India IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Australia IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. China Taiwan IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Indonesia IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Thailand IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Malaysia IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America IVD Antibody Sales Market Share by Country (2021–2032)

Figure 47. Latin America IVD Antibody Revenue Market Share by Country (2021–2032)

Figure 48. Mexico IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Middle East and Africa IVD Antibody Sales Market Share by Country (2021–2032)

Figure 52. Middle East and Africa IVD Antibody Revenue Market Share by Country (2021–2032)

Figure 53. Turkey IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Saudi Arabia IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. UAE IVD Antibody Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Global Sales Market Share of IVD Antibody by Type (2021–2032)

Figure 57. Global Revenue Market Share of IVD Antibody by Type (2021–2032)

Figure 58. Global IVD Antibody Price (US$/Unit) by Type (2021–2032)

Figure 59. Global Sales Market Share of IVD Antibody by Application (2021–2032)

Figure 60. Global Revenue Market Share of IVD Antibody by Application (2021–2032)

Figure 61. Global IVD Antibody Price (US$/Unit) by Application (2021–2032)

Figure 62. IVD Antibody Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global IVD Antibody market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global IVD Antibody market is 8.0% 2026 to 2032.

Which companies rank high in the global IVD Antibody market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of IVD Antibody in 2032? shouQi

What was the global market size of IVD Antibody in 2026? shouQi

Related Reports

IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for IVD Antibody was estimated to be worth US$ 999 million in 2025 and is projected to reach US$ 1699 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 135
USD 3950.00
(Single User License)
Global IVD Antibody Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global IVD Antibody market size was US$ 932 million in 2024 and is forecast to a readjusted size of US$ 1585 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global IVD Antibody Market Outlook, In‑Depth Analysis & Forecast to 2031
The global IVD Antibody market is projected to grow from US$ 932 million in 2024 to US$ 1585 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 133
USD 4900.00
(Single User License)
IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for IVD Antibody was estimated to be worth US$ 932 million in 2024 and is forecast to a readjusted size of US$ 1585 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 101
USD 3950.00
(Single User License)
Global IVD Antibody Market Research Report 2025
The global market for IVD Antibody was valued at US$ 932 million in the year 2024 and is projected to reach a revised size of US$ 1585 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published Date: 2025-01-13
Pages: 83
USD 2900.00
(Single User License)
Global IVD Antibody Market Insights, Forecast to 2030
IVD Antibody
Published Date: 2024-04-15
Pages: 99
USD 4900.00
(Single User License)
Global IVD Antibody Market Research Report 2024
IVD Antibody
Published Date: 2024-01-17
Pages: 80
USD 2900.00
(Single User License)

IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for IVD Antibody was estimated to be worth US$ 999 million in 2025 and is projected to reach US$ 1699 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 135
USD 3950.00 (Single User License)
Global IVD Antibody Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global IVD Antibody market size was US$ 932 million in 2024 and is forecast to a readjusted size of US$ 1585 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)
Global IVD Antibody Market Outlook, In‑Depth Analysis & Forecast to 2031
The global IVD Antibody market is projected to grow from US$ 932 million in 2024 to US$ 1585 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 133
USD 4900.00 (Single User License)
IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for IVD Antibody was estimated to be worth US$ 932 million in 2024 and is forecast to a readjusted size of US$ 1585 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 101
USD 3950.00 (Single User License)
Global IVD Antibody Market Research Report 2025
The global market for IVD Antibody was valued at US$ 932 million in the year 2024 and is projected to reach a revised size of US$ 1585 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published: 2025-01-13
Pages: 83
USD 2900.00 (Single User License)
Global IVD Antibody Market Insights, Forecast to 2030
IVD Antibody
Published: 2024-04-15
Pages: 99
USD 4900.00 (Single User License)
Global IVD Antibody Market Research Report 2024
IVD Antibody
Published: 2024-01-17
Pages: 80
USD 2900.00 (Single User License)